Check Cap Ltd
Check Cap Ltd has a market price of $1.79 and a market cap of $12,566,698.58, indicating a relatively small market capitalization. The company's financial snapshot shows that the number of shares outstanding is the same for both basic and diluted shares, at 7,020,502, suggesting no immediate dilution risk. The company's profitability is currently negative, as evidenced by the last actual EPS of -3.00, which indicates a loss per share. This loss per share is a significant concern when compared to industry standards, as it suggests the company is not generating positive returns for its shareholders at this time. There is no detailed information provided on the company's segments or geographic exposure, which limits the ability to assess revenue concentration or diversification. Without this data, it is difficult to determine the extent to which the company's performance is tied to specific markets or product lines. The company's growth trajectory is not clearly defined, as there is no outlook data provided for the current or next fiscal year. The absence of growth projections makes it challenging to assess the company's future performance or potential for expansion. The risk assessment indicates that liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents. This lack of information is a red flag for investors, as it suggests that the company's ability to meet its short-term obligations is uncertain. Recent events or filings that could impact the company's operations or financial status are not detailed in the provided data. This absence of recent events makes it difficult to gauge the company's current situation or any potential changes that may affect its performance.
Business. Check Cap Ltd operates in the healthcare sector, specifically within the biotechnology and medical research industry, focusing on pharmaceuticals and medical research.
Classification. Check Cap Ltd is classified under the industry of Biotechnology & Medical Research within the Pharmaceuticals & Medical Research business sector, with a classification confidence of 0.92.
- Check Cap Ltd is a small-cap company in the biotechnology and medical research industry.
- The company is currently reporting a loss per share, indicating poor profitability.
- There is no immediate dilution risk as the number of basic and diluted shares is the same.
- The company's liquidity risk could not be assessed due to insufficient data.
- The company's growth trajectory and future performance are unclear without additional outlook data.
- # RATIONALES
- **margin_outlook_rationale**: The company's margin outlook is negative due to the reported loss per share.
- **rd_outlook_rationale**: There is no specific information provided on the company's research and development outlook.
- Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).